Magdalena Kotańska Selected Research

MH-76 compound

5/2021	MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats.
1/2019	Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
1/2019	Beneficial effects of non-quinazoline α1-adrenolytics on hypertension and altered metabolism in fructose-fed rats. A comparison with prazosin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Kotańska Research Topics

Disease

11	Obesity 06/2022 - 01/2017
10	Body Weight (Weight, Body) 01/2022 - 01/2017
6	Hypertension (High Blood Pressure) 01/2022 - 07/2017
4	Weight Gain 06/2022 - 01/2018
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2018
3	Inflammation (Inflammations) 05/2021 - 01/2020
3	Insulin Resistance 05/2021 - 01/2019
2	Hypertrophy 06/2022 - 01/2019
2	Hyperglycemia 01/2022 - 01/2019
2	Nausea 10/2021 - 01/2018
2	Hyperphagia (Overeating) 09/2021 - 01/2018
2	Pica (Geophagia) 01/2018 - 01/2017
1	Fatigue 01/2022
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2021
1	Necrosis 05/2021
1	Myocardial Infarction 05/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Edema (Dropsy) 03/2021
1	Dementia (Dementias) 01/2021
1	Hyperalgesia 01/2020
1	Pain (Aches) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 12/2019
1	Cognitive Dysfunction 07/2019
1	Alzheimer Disease (Alzheimer's Disease) 07/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hypertriglyceridemia 01/2019

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 06/2022 - 07/2019
6	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2017
5	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2019
4	LipidsIBA 05/2021 - 01/2016
3	MH-76 compoundIBA 05/2021 - 01/2019
3	QuinazolinesIBA 05/2021 - 01/2019
3	Prazosin (Minipress)FDA LinkGeneric 05/2021 - 01/2019
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2021 - 05/2018
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2022 - 09/2021
2	LeptinIBA 06/2022 - 05/2021
2	Interleukin-6 (Interleukin 6)IBA 05/2021 - 03/2021
2	FructoseIBA 05/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 05/2021 - 01/2019
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2021 - 01/2020
2	CarrageenanIBA 03/2021 - 01/2020
2	CorticosteroneIBA 01/2020 - 01/2017
2	pitolisantIBA 01/2020 - 01/2018
2	Serotonin ReceptorsIBA 12/2019 - 07/2019
2	AntioxidantsIBA 07/2019 - 01/2019
2	SaltsIBA 01/2019 - 07/2017
2	MH-79 compoundIBA 01/2019 - 01/2019
2	Appetite Depressants (Anorectics)IBA 01/2018 - 01/2017
2	HBK-15IBA 01/2017 - 01/2016
1	sigma-2 receptorIBA 06/2022
1	Triglycerides (Triacylglycerol)IBA 06/2022
1	ResistinIBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CateninsIBA 01/2022
1	Guanabenz (BR 750)FDA Link 01/2022
1	KaolinIBA 10/2021
1	ClayIBA 10/2021
1	Histamine H3 AntagonistsIBA 10/2021
1	Betahistine (Serc)IBA 09/2021
1	Antipsychotic Agents (Antipsychotics)IBA 09/2021
1	Hormones (Hormone)IBA 09/2021
1	PiperazineIBA 05/2021
1	Plasminogen Activator Inhibitor 1IBA 05/2021
1	Doxazosin (Cardura)FDA LinkGeneric 05/2021
1	Insulin (Novolin)FDA Link 05/2021
1	psb-603IBA 03/2021
1	Adenosine (Adenocard)FDA LinkGeneric 03/2021
1	ZymosanIBA 03/2021
1	CytokinesIBA 03/2021
1	Adenosine A2B ReceptorIBA 03/2021
1	Adenosine A2 Receptor AntagonistsIBA 03/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Capsaicin (Zostrix)FDA Link 01/2020
1	Purinergic P1 Receptor AntagonistsIBA 01/2020
1	Ketoprofen (Orudis)FDA LinkGeneric 01/2020
1	acetoacetic acid (acetoacetate)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	pyridineIBA 01/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2020
1	TriazinesIBA 12/2019
1	SulfonesIBA 12/2019
1	HydantoinsIBA 12/2019
1	indoleIBA 12/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 12/2019
1	Serotonin (5 Hydroxytryptamine)IBA 07/2019
1	ButyrylcholinesteraseIBA 07/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2019
1	Acetates (Acetic Acid Esters)FDA Link 01/2019
1	Drinking WaterIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2019
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2019

Therapy/Procedure

2	Therapeutics 05/2021 - 08/2018
1	Drug Therapy (Chemotherapy) 01/2020
1	Secondary Prevention 12/2018